➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Express Scripts
Johnson and Johnson
Mallinckrodt
McKinsey

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

MALATHION - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for malathion and what is the scope of patent protection?

Malathion is the generic ingredient in two branded drugs marketed by Mylan Pharms Inc, Suven Pharms, and Taro Pharm Inds Ltd, and is included in three NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Malathion has ten patent family members in seven countries.

There are three drug master file entries for malathion. Two suppliers are listed for this compound.

Drug Prices for MALATHION

See drug prices for MALATHION

Drug Sales Revenue Trends for MALATHION

See drug sales revenues for MALATHION

Recent Clinical Trials for MALATHION

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
London School of Hygiene and Tropical MedicinePhase 3
Taro Pharmaceuticals USAPhase 1
Taro Pharmaceuticals USAPhase 2/Phase 3

See all MALATHION clinical trials

Pharmacology for MALATHION
Medical Subject Heading (MeSH) Categories for MALATHION
Paragraph IV (Patent) Challenges for MALATHION
Tradename Dosage Ingredient NDA Submissiondate
OVIDE LOTION;TOPICAL malathion 018613 2011-03-16

US Patents and Regulatory Information for MALATHION

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc MALATHION malathion LOTION;TOPICAL 078743-001 Mar 6, 2009 DISCN No No   Start Trial   Start Trial   Start Trial
Taro Pharm Inds Ltd OVIDE malathion LOTION;TOPICAL 018613-001 Aug 2, 1982 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
Taro Pharm Inds Ltd OVIDE malathion LOTION;TOPICAL 018613-001 Aug 2, 1982 DISCN Yes No   Start Trial   Start Trial Y Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Mallinckrodt
Johnson and Johnson
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.